Selected Publications
- Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers. Brandon M. Lehrich, Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao, Yuqing Liu, Mohammad N. Taheri, Xiangnan Guan, Hartmut Koeppen, Sucha Singh, Vik Meadows, Jia Jun Liu, Anya Singh-Varma, Yekaterina Krutsenko, Minakshi Poddar, T. Kevin Hitchens, Lesley M. Foley, Binyong Liang, Alex Rialdi, Ravi P. Rai, Panari Patel, Madeline Riley, Aaron Bell, Reben Raeman, Tulin Dadali, Jason J. Luke, Ernesto Guccione, Mo R. Ebrahimkhani, Amaia Lujambio, Xin Chen, Martin Maier, Yulei Wang, Wendy Broom, Junyan Tao, Satdarshan P. Monga. Nature Communications
- Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenance. Praveen Agrawal, Shuhui Chen, Ana de Pablos, Yellamandayya Vadlamudi, Fatemeh Vand-Rajabpour, Faezeh Jame-Chenarboo, Swarnali Kar, Amanda Flores Yanke, Pietro Berico, Eleazar Miera Saenz de Vega, Farbod Darvishian, Iman Osman, Amaia Lujambio, Lara K. Mahal, Eva Hernando. Science advances
- NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma. Katherine E. Lindblad, Romain Donne, Ian Liebling, Marina Barcena-Varela, Anthony Lozano, Marina Ruiz de Galarreta, Maxime Dhainaut, Nesteene J. Param, Bruno Giotti, Sarah Cappuyns, Takahiro Kodama, Yulei Wang, Alice O. Kamphorst, Alexander M. Tsankov, Amaia Lujambio. Cancer Discovery